InvestSMART

Control Bionics Limited (ASX:CBL)

ALERT: Price-sensitive ASX Announcement for CBL
Current share price for CBL : $0.069 -0.018 (-20.69%)+
Announcement
Release
25 Jun 2026 10:40AM
Price at Release
$0.087
Full Release
download
Summary
Control Bionics Limited has announced a capital raising initiative, securing firm commitments for a $9.5 million placement and launching a $0.5 million Share Purchase Plan (SPP). The placement involves issuing new shares at a price of $0.075 per share, representing a discount to the recent market price. The funds will support the company's commercial expansion and development initiatives, including enhancing medical technology. The placement is structured in two tranches, with Tranche 2 requiring shareholder approval. Additionally, a non-underwritten SPP will allow eligible shareholders to purchase shares under the same terms. The capital raised will bolster Control Bionics' efforts to expand its global footprint in neurotechnology markets.
Key Points
  • Control Bionics Limited secures $9.5 million through placement.
  • Launch of $0.5 million Share Purchase Plan.
  • Placement priced at $0.075 per share, a 14.5% discount.
  • Tranche 2 of the placement requires shareholder approval.
  • Funds to be used for commercial expansion and technology development.
  • Share Purchase Plan available to Australian and New Zealand shareholders.
  • Joint Lead Managers Bell Potter Securities and Unified Capital Partners involved.
  • SPP to raise up to $500,000 with potential scale-back.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.